OKYO Pharma Limited (OKYO)
NASDAQ: OKYO · IEX Real-Time Price · USD
2.17
+0.05 (2.36%)
At close: Aug 8, 2022 3:59 PM
2.19
+0.02 (0.69%)
After-hours:
Aug 8, 2022 6:32 PM EDT
Cash Flow Statement (Annual)
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
| Year | 2020 | 2019 |
|---|---|---|
| Net Income
|
-3.35 | -1.54 |
| Depreciation & Amortization
|
0.01 | 0.01 |
| Share-Based Compensation
|
0.54 | 0.04 |
| Other Operating Activities
|
1.2 | 0.3 |
| Operating Cash Flow
|
-1.6 | -1.2 |
| Capital Expenditures
|
-0.01 | 0 |
| Acquisitions
|
-0.01 | -0.13 |
| Investing Cash Flow
|
-0.02 | -0.13 |
| Share Issuance / Repurchase
|
0.25 | 0.99 |
| Debt Issued / Paid
|
7.58 | 0.49 |
| Other Financing Activities
|
0 | -0.52 |
| Financing Cash Flow
|
7.83 | 0.96 |
| Net Cash Flow
|
6.21 | -0.37 |
| Free Cash Flow
|
-1.61 | -1.2 |
| Free Cash Flow Per Share
|
-0.07 | - |
Source: Financials are provided by
Nasdaq Data Link
and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).